rs1386133319
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_152709.5(STOX1):c.134C>G(p.Ala45Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152709.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000184 AC: 2AN: 108404Hom.: 0 Cov.: 13
GnomAD4 exome Cov.: 8
GnomAD4 genome AF: 0.0000184 AC: 2AN: 108474Hom.: 0 Cov.: 13 AF XY: 0.00 AC XY: 0AN XY: 52672
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.134C>G (p.A45G) alteration is located in exon 1 (coding exon 1) of the STOX1 gene. This alteration results from a C to G substitution at nucleotide position 134, causing the alanine (A) at amino acid position 45 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at